EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Maternal Haemoglobin and Haematocrit During Pregnancy and Stillbirth Risk: A Prospective, Population‐Based Birth Cohort Study

Shuangying Li iD, Nina Dempsey, Shen Gao, Shaofei Su, Shuanghua Xie, Zhengyang Yao, Minhui Hu iD, Juan Li, Zhan Li, Enjie Zhang, Jianhui Liu, Hao Xing und 6 weitere

Paediatric and Perinatal Epidemiology · 2026

DOI: 10.1111/ppe.70144 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Paediatric and Perinatal Epidemiology, 2026. Verfasst von Shuangying Li und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Central Laboratory, Beijing Obstetrics and Gynecology Hospital, Capital Medical University. Beijing Maternal and Child Health Care Hosp…. Hauptthemen laut MEDLINE: Stillbirth, Hemoglobins, Anemia, Pregnancy Complications, Hematologic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, China Scholarship Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Maternal anaemia is a public health issue globally, associated with adverse maternal and neonatal outcomes. However, less is known about the effects of high haemoglobin (Hb) and haematocrit (Hct) on the risk of stillbirth.

Objectives

We assessed the dose–response effects of dynamic changes in maternal Hb and Hct across all trimesters on stillbirth risk.

Methods

This study was based on the prospective, longitudinal, population‐based China birth cohort study (CBCS) between 2018 and 2022, including 142,715 women with live births or stillbirths delivered at ≥ 20 weeks' gestation. The modified Poisson regression models were used to assess the association between Hb/Hct, haemodilution status across three trimesters and stillbirth.

Results

Over a fifth (23.6%) of pregnant women had anaemia at least once during pregnancy. Maternal anaemia increased the risk of stillbirth. The adjusted risk ratio (aRR) for Hb at 70–99 g/L (moderate anaemia) was 2.45, 95% confidence interval (CI) 1.26, 4.76 and aRR for Hct < 33% (anaemia) was 1.63 (95% CI 1.12, 2.38) in the first trimester. Interestingly, a U‐shaped association between Hb/Hct and stillbirth was observed, and high Hb/Hct levels in any of the three trimesters were related to increased stillbirth risk. Excessive haemoglobin dilution/haemoglobin concentration across trimesters was also associated with higher stillbirth risk, especially from the first to the second trimesters, with aRRs of 1.86 (95% CI 1.15, 3.01) and 3.34 (95% CI 2.08, 5.37), respectively.

Conclusions

Considering the U‐shaped association between Hb/Hct levels and stillbirth, clinical vigilance is necessary at both low‐ and high‐extremes of Hb/Hct and physiological haemodilution metrics in mid‐to‐late pregnancy for improved pregnancy outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

StillbirthHemoglobinsAnemiaPregnancy Complications, HematologicHumansFemalePregnancyProspective StudiesAdultHematocritChinaRisk FactorsPregnancy TrimestersBirth CohortLongitudinal Studies

Stichwörter der Autor:innen

anaemiahaematocrit levelshaemodilutionhaemoglobin concentrationsstillbirth

Substanzen

Hemoglobins

Autor:innen und Institutionen

  • Department of Central Laboratory, Beijing Obstetrics and Gynecology Hospital, Capital Medical University. Beijing Maternal and Child Health Care Hospital, Beijing, China.
  • Department of Life Sciences, Faculty of Science and Engineering, Manchester Metropolitan University, Manchester, UK.
  • Department of Obstetrics, Beijing Obstetrics and Gynecology Hospital, Capital Medical University. Beijing Maternal and Child Health Care Hospital, Beijing, China.
  • Department of Research Management, Beijing Obstetrics and Gynecology Hospital, Capital Medical University. Beijing Maternal and Child Health Care Hospital, Beijing, China.
  • Maternal and Fetal Health Research Centre, Division of Developmental Biology and Medicine, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
  • Saint Mary's Hospital, Manchester University NHS Foundation Trust, Manchester, UK.

ORCID-Profile: Shuangying Li, Minhui Hu, Wentao Yue, Alexander E P Heazell, Chenghong Yin

Förderung

  • National Key Research and Development Program of China
  • China Scholarship Council

Zitieren

APA

Li, S., Dempsey, N., Gao, S., Su, S., Xie, S., Yao, Z., Hu, M., Li, J., Li, Z., Zhang, E., Liu, J., Xing, H., Yu, J., Wu, S., Yue, W., Liu, R., Heazell, A. E. P., & Yin, C. (2026). Maternal Haemoglobin and Haematocrit During Pregnancy and Stillbirth Risk: A Prospective, Population‐Based Birth Cohort Study. Paediatric and Perinatal Epidemiology. https://doi.org/10.1111/ppe.70144

Vancouver

Li S, Dempsey N, Gao S, Su S, Xie S, Yao Z, et al. Maternal Haemoglobin and Haematocrit During Pregnancy and Stillbirth Risk: A Prospective, Population‐Based Birth Cohort Study. Paediatric and Perinatal Epidemiology. 2026. doi:10.1111/ppe.70144

BibTeX
@article{Li2026,
  author = {Li, Shuangying and Dempsey, Nina and Gao, Shen and Su, Shaofei and Xie, Shuanghua and Yao, Zhengyang and Hu, Minhui and Li, Juan and Li, Zhan and Zhang, Enjie and Liu, Jianhui and Xing, Hao and Yu, Jinghan and Wu, Shaowen and Yue, Wentao and Liu, Ruixia and Heazell, Alexander E P and Yin, Chenghong},
  title = {Maternal Haemoglobin and Haematocrit During Pregnancy and Stillbirth Risk: A Prospective, Population‐Based Birth Cohort Study},
  journal = {Paediatric and Perinatal Epidemiology},
  year = {2026},
  doi = {10.1111/ppe.70144}
}
Kostenlos starten →